Wearable Patch Market: Recent Industry Trends and Projected Industry Size by 2020-2027

Wearable patches are generally known as electronic skin or smart patches. These patches are thin, small, and flexible in nature, and consist of various electronic components such as sensors, actuators, and energy storage and communication systems. These collect data at regular intervals and transmit it to connected smartphones or health information systems (HIS). Wearable patches facilitate continuous monitoring of physiological parameters and various complex electrocardiogram measurements without tethering patients to a wired hub

The global wearable patch market was valued at $12.2 billion in 2019, and is projected to reach $27.8 billion by 2027, registering a CAGR of 9.6% from 2020 to 2027.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/10723

Increase in technological advancements in wearable patches, rise in prevalence of chronic diseases, and growth in awareness among consumers regarding wearable patches are the major factors that boost the market growth. In addition, benefits of wearable patches for providers and patients, coupled with rise in awareness among users or patients are further propel the wearable patch market growth. Wearable patches help in monitoring diseases on regular basis. Moreover, these patches keep a track of regular physical activities and suggest recommendations to users. Furthermore, these wearable patches can be easily covered under cloth and do not restrain movement of a person. Wearable patches are compatible with most mobile operating systems and can be easily connected through Bluetooth, hence are preferred alternatives to smart watches and fitness bands. In addition, connected wearables are portable in nature, feature wireless connectivity, and are mostly used to monitor heart rate via Bluetooth. Rise in adoption of connectivity technologies, such as microprocessor controllers, Bluetooth, and myoelectric technology propels the demand of connected wearable patches and thereby support the wearable patch market growth.

The global wearable patch market is segmented on the basis of product, end use, and region. On the basis of product, the market is divided into temperature patch, blood glucose patch, blood pressure patch, heart rate patch & ECG patch, skin care patch, and others. The blood glucose patch segment dominated the market in 2019 as numerous patients suffering from diabetes are advised to monitor blood glucose on a regular basis to prevent development of hyperglycemia and hypoglycemia, and to facilitate control over diabetes.

For Purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/10723

By end use, the market is classified into healthcare and fitness and sports. Healthcare or medical/clinical use wearable patches are intended for diagnosis, treatment, or management of certain diseases. On the other hand, fitness and sports wearable patches are used by athletes to get health related data insights to support optimal energy strategy and performance. The fitness and sports segment is expected to represent favorable market growth during the forecast period attributed to rise in use of biosensors by athletes to optimize their sport performance.

Region wise, the wearable patch market analyzed across North America, Europe, Asia-Pacific, and LAMEA. The North America market was dominant, in terms of revenue among other regions in 2019, owing to rise in prevalence of target diseases, presence of advanced healthcare infrastructure, as well as presence of major market participants such as Abbott Laboratories, iRhythm Technologies, Inc., Johnson & Johnson Services, Inc., LifeSignals, Inc., Qualcomm Technologies, Inc., and VitalConnect, Inc. For instance, as per data published by the American Heart Association (AHA), in February 2019, cardiovascular disease (CVD) remains the leading cause of death in the U.S. There are about 2.7 million Americans living with atrial fibrillation and around 800,000 individuals encounter stroke, every year. This is expected to propel demand for wearable patches in the coming years.

Moreover, the market in Asia-Pacific is expected to register fastest CAGR, in terms of revenue, during the forecast period pertaining to rise in awareness regarding wearable patches, rise in disposable income, and increase in use of wearable patches in India, China, and Japan.

Access Full Report @ https://www.alliedmarketresearch.com/wearable-patch-market-A10358

Wearable patch market players are adopting growth strategies such as product launches, mergers and acquisitions (M&As), and partnerships and collaborations to create sustainable position in the market. For instance, in October 2019, Abbott Laboratories partnered with Omada Health and Tandem Diabetes Care in order to increase the impact of its FreeStyle Libre technology.

The Major Key Players Are:

Abbott Laboratories, iRhythm Technologies, Inc., Johnson & Johnson Services, Inc., Koninklijke Philips N.V., L’Oreal Group, LifeSignals, Inc., Medtronic Plc (Zephyr Technology Corporation), Qualcomm Technologies, Inc., VitalConnect, Inc., and VivaLNK.

Key Findings Of The Study:

• On the basis of product, the blood glucose patch segment was the highest contributor to the market in 2019.
• Based on end use, the fitness and sports segment is anticipated to register fastest CAGR during the forecast period
• Region wise, North America accounted for the largest revenue share in 2019; while Asia-Pacific is anticipated to grow at the highest CAGR during the review period

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

Blood Purification Equipment Market Interesting Facts, I Bet You Never Knew About This in 2027

Blood from the patient’s body is circulated through an external equipment or device for removal of toxin, endotoxin, or impurities and is returned to the patient’s body with the help of blood collection tubing. This process is termed as blood purification. Nowadays, blood purification technique is widely used for treating several disorders that are refractory to traditional therapies, such as surgeries and drug administration. Blood purification works by eliminating pathogenic agents and toxins from blood using numerous other bio-separation procedures such as filtration, dialysis or adsorption. Owing to these advantages over conventional methods, blood purification is majorly preferred in various autoimmune and metabolic disorder treatments. Presently, the most known application of blood purification technique is hemodialysis treatment. Large patient population suffering from kidney failure is stimulating the demand for development of sophisticated equipment and devices for blood purification in these hemodialysis patients. As a result of which, pharmaceutical players in the market are investing in R&D of these equipment, thereby, driving the growth of the market. Furthermore, medical discoveries in the fields of hematology and pathophysiology of diseases have significantly extended the application of blood purification. This has ultimately resulted in increased demand for blood purification devices in the past few years and is expected to continue over the analysis period.

The global blood purification equipment market size was valued at $14.62 billion in 2019, and is projected to reach $23.93 billion by 2027, registering a CAGR of 5.6% from 2020 to 2027. 

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/10668

On the other hand, COVID-19 pandemic has impacted every industry vertical worldwide. The existing scenario evidently states that COVID-19 will continue to limit several aspects of the healthcare sector in foreseeable future, up until an effective treatment can be made accessible to the population on a larger scale. Accordingly, the impact of the pandemic on the healthcare system is possibly expected to be deeper and long lasting. The nationwide lockdowns, government regulations, and continuous increase in infection rate across numerous countries has created a widespread financial impact on hospitals, dialysis centers and clinics. Several dialysis clinics have cancelled, or postponed, the treatments deemed to be non-urgent. Furthermore, intermittent supply chain activities and absence of human resources impacted the market growth rate to a great extent. However, COVID-19 is foreseen to have a stronger influence on the blood purification equipment market growth. As the restrictions are easing slowly across the world, the market is anticipated to gain traction in near future, due to upsurge in research activities mainly focused on using blood purification as a method to limit the transmission of COVID-19 infection. Numerous companies have approached the U.S. FDA for filing emergency use authorization (EUA) in order to use their blood purification equipment for treating patients with COVID-19. Therefore, the pandemic is expected to have a positive impact on the overall market growth.

The report segments the global blood purification equipment market based on type into portable and stationary. Portable segment dominated the blood purification equipment market in 2019, and is estimated to register a CAGR of 5.7% from 2020 to 2027. This is attributed to the benefits offered by portable equipment over stationary devices. These blood purification equipment are mobile and can be transferred from one critical care unit to other, thereby avoiding patient’s discomfort and usually occupy lesser space than stationary equipment. Thus, growing acceptance and adoption of portable equipment by healthcare professionals is expected to have a positive impact on the segment growth.

For Purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/10668

Based on indication, the blood purification equipment market can be divided intosepsis, renal diseases, and others. The renal disease segment is expected to garner the largest share in blood purification equipment market due to the increasing prevalence of kidney related diseases among the population. For instance, as per the data published by National Kidney Foundation, approximately 10% of the population across the globe is affected by chronic kidney disease (CKD). As dialysis plays a vital role in treating patients with kidney disorders, the demand for blood purification equipment used in the dialysis treatments is ultimately expected to increase over next few years. 

Based on end user, the market is segmented into hospitals and clinics, dialysis centers and others. The dialysis centers segment dominated the blood purification equipment market in 2019, generating $7,689.40 million in 2019, and is expected to garner $12,641.76 million by 2027, registering a CAGR of 5.7% from 2020 to 2027. This growth is attributed to the upsurge in number of patient population opting for dialysis. Likewise, numerous government and private organizations undertake in-center dialysis programs and provide their services to patients suffering from end stage renal disease (ESRD)and chronic kidney diseases (CKDs). Likewise, majority of companies involved in manufacturing of blood purification equipment are also engaged in developing dialysis centers in various regions. For instance, Fresenius Medical Care, a prominent player in the market alone has 4,000 dialysis clinics operating globally as of 2020. Thus, these factors are collectively responsible for the growth of the end user segment. 

Presently, Asia-Pacific and North America are the most lucrative regions for market players, owing to increase in awareness about blood purification equipment and devices among healthcare professionals & patients, developments in healthcare infrastructure, and higher prevalence of ESRD and CKDs.

The Major Key Players Are:

Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Fresenius SE and Co. KGaA, Healthwell Medical Tech. Co., Ltd., Infomed SA, Jafron Biomedical Co., Ltd., Kaneka Corporation, Nikkiso Co, ltd. and SWS Medical Group.

Access Full Report @ https://www.alliedmarketresearch.com/blood-purification-equipment-market-A10303

Key Findings Of The Study 

• Based on indication, the renal diseases segment is projected to grow at the highest rate during the analysis period.
• By product type, portable equipment dominated the global blood purification equipment market throughout the forecast period.
• Based on region, Asia-Pacific was the largest blood purification equipment market share in 2019, and is projected to maintain its lead until 2027.
• By end user, the dialysis centers segment is projected to dominate throughout 2027.

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

E-health Market To Receive Overwhelming Hike In Revenues By 2027

According to the report by Allied Market Research, the global E-Health market is estimated to register a CAGR of 14.5% from 2020 to 2027. The research helps leading players and startups to devise new strategies based on current market trends and changing dynamics. Competitive landscape is mentioned in the report based on business segments, products portfolio, and strategic moves & developments of leading market players. Detailed segmentation assists in determining growing segments and determining further steps to capitalize on lucrative segments. Regional landscape is helpful in determining opportunities and driving factors of each region and taking further steps.

E-health is the delivery of healthcare using modern electronic information and communication technologies when healthcare providers and patients are not directly in contact and their interaction is mediated by electronic means. Among other things, the services that are thus provided include physical and psychological diagnosis and treatment, telepathology, vital signs monitoring, electronic prescribing, teleconsultation, and others. Furthermore, automated and interoperable healthcare information systems improve medical care, minimize healthcare costs, reduce manual errors, and enhance patient satisfaction, while optimizing reimbursement for ambulatory and inpatient healthcare providers.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/10531

The COVID-19 pandemic is expected to present growth opportunities for e-health market in the future. The e-health market includes major suppliers such as Cerner Corporation, GE Healthcare, and Allscripts.

These suppliers have their manufacturing facilities across North America, Asia-Pacific, Europe, South America, and RoW. For instance, In April 2020, GE Healthcare extended its longtime collaboration with Microsoft to launch a cloud-based COVID-19 patient monitoring software for health systems, which will further boost the market growth. In addition, e-health providers has undertaken the task of providing a global overview of the e-health solutions available for COVID-19. Solution providers, consultants advising the healthcare system, and healthcare professionals have been prompted on the internet to contribute with solutions for COVID-19. Many e-health provider companies providing solutions across institutions, geographies, and countries.

The growth of the global e-health market is majorly driven by extensive use of software & ICT healthcare, surge in need to manage regulatory compliance through use of e-health solution, availability of infrastructure for implementation of e-health and safe and adequate storage of data. Furthermore, with fast and easy data sharing, e-health solutions foster collaboration among healthcare providers, while enabling to improve patient outcomes and increasing patient safety. However, reluctance among medical professionals to adopt advanced e-health solutions and high cost of deployment and maintenance of e-health solutions hinder the market growth. Conversely, growth opportunities in emerging nations; expansion of mHealth, telehealth, and remote patient monitoring markets; and rise in use of e-health solutions in outpatient care facilities are expected to provide lucrative growth opportunities for the market growth.

For Purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/10531

By product, the medical apps segment is anticipated to grow with the largest share throughout the forecast period. This is attributed to increase significantly, owing to rise in demand for quality healthcare services & solutions, increase in acceptance of mHealth practices, surge in demand for improved patient safety & patient care, and increase in government initiatives to promote healthcare information technology (HCIT). Moreover, surge in adoption of smartphones, tablets, and other devices notably contributes toward the growth of the market.

North America accounted for the highest revenue in 2019, and is anticipated to maintain its dominance from 2020 to 2027, due to favorable regulatory scenario regarding to e-health, high adoption of e-health solutions to curtail soaring healthcare costs, regulatory requirements regarding patient safety, and presence of a large number of e-health companies, such as Allscripts Healthcare Solutions, Cerner Corporation, GE Healthcare, and McKesson Corporation, Infor, Inc.

The Major Key Players Are:

Allscripts Healthcare Solutions, Inc., Athenahealth, Inc., Cisco Systems, Inc., InTouch Health, International Business Machines Corporation (IBM), General Electric Company (GE Healthcare), Medtronic plc., UnitedHealth Group (Optum), Koninklijke Philips N.V., and Siemens Healthineers.

Key Findings Of The Study

• By product, the medical apps segment occupied 41.7% share of the global e-health market in 2019.
• On the basis of end user, the healthcare consumers segment is anticipated to grow with the highest CAGR throughout the forecast period.
• Region wise, the Asia-Pacific e-health market is anticipated to exhibit a CAGR of 23.02% during the forecast period.

Access Full Report @ https://www.alliedmarketresearch.com/ehealth-market-A10166

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

Blood Pressure Monitoring Devices Market Statistics 2020: Top Impacting Factors That Can Win the Industry Worldwide

 

Blood pressure is considered as one of the main risk factors for chronic heart disease. Advanced blood pressure monitoring devices are used for regular remote monitoring and transmission of the blood pressure data to the physicians. Factors such as increase in geriatric population, rise in inclination towards home monitoring, and upsurge in incidence rate of chronic diseases, such as cardiovascular disorders and obesity, are expected to drive the market. Moreover, innovations in blood pressure monitoring devices, (such as introduction of digital blood pressure monitors) and rise in awareness among patients regarding advanced devices are expected to fuel the market growth. However, lack of awareness about these devices in low- and middle-income economies hampers the market growth.

The global blood pressure monitoring devices market was valued at $1,981 million in 2015, and is estimated to reach $2,926 million by 2022, registering a CAGR of 5.7% from 2016 to 2022. Digital blood pressure monitoring devices segment held around two-fifths share of the total market in 2015.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/2166

Digital blood pressure monitoring devices segment is anticipated to dominate the global blood pressure monitoring devices market owing to the increase in the global incidence of hypertension. However, ambulatory blood pressure monitors segment is projected to be the fastest growing segment, as a result of increase in the outpatient cases and reimbursement support from the government.

Digital BP monitors at hospitals & clinics segment is expected to dominate the global blood pressure monitoring devices market, as these devices facilitate easy and early detection of a patients deteriorating health condition, thereby, enabling speedy intervention and diagnosis of diseases. However, the ambulatory BP monitoring devices at ambulatory surgical centers (ASCs) market is projected to be the fastest growing segment, owing to increase in the number of outpatient cases.

Inquire before buying @  https://www.alliedmarketresearch.com/purchase-enquiry/2166

North America was the highest revenue contributor to the global revenue in 2015, accounting for about two-fifths share, and is expected to maintain this trend. This is attributed to the increase in prevalence of hypertension, growth in awareness among patients about cost-effective blood pressure monitoring devices, and availability of advanced healthcare facilities in North American countries. However, Asia-Pacific is expected to grow at the highest rate, owing to its high population base, incomes, and improvement in patient awareness about advanced blood pressure monitoring devices.

The Major Key Players Are:

·        A&D Company, Limited

·        Contec Medical Systems Co., Ltd.

·        General Electric Company

·        Halma plc

·        Hill-Rom Holdings, Inc.

·        Koninklijke Philips N.V.

·        Masimo Corporation

·        Nihon Kohden Corporation

·        Omron Corporation

·        Smiths Group Plc.

Key Findings of the Blood Pressure Monitoring Devices Market Study:

·        Based on product type, in 2015, digital blood pressure monitoring devices segment accounted for around two-fifths share of the total market.

·        Home environment segment is expected to grow at a significant CAGR of 6.5%, as these devices can be easily used by a patient and do not require trained professionals for operating the device.

·        LAMEA is projected to be the one of the fastest growing region, owing to the presence of ample growth opportunities in terms of unmet medical needs for the treatment of hypertension, and increased disposable income of the population.

·        In 2015, Japan and China jointly accounted for about two-thirds share of the Asia-Pacific blood pressure monitoring devices market.

Access Full Report @  https://www.alliedmarketresearch.com/blood-pressure-monitoring-devices-market

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Ophthalmic Lasers market CAGR Attempts To Break Record Estimating By 2027

A laser is a device that emits light through a process of optical amplification based on the stimulated emission of electromagnetic radiation. This device is used increasingly in the area of ophthalmology as there is an understanding of laser-tissue interactions in this medical application, such as ophthalmology. This results into use of medical lasers in treating a wide spectrum of eye-related diseases, such as cataract, glaucoma, age-related macular edema, and diabetic retinopathy.

The global ophthalmic lasers market was valued at $1,111 million in 2016, and is projected to reach $1,516 million by 2023, registering a CAGR of 4.5% from 2017 to 2023. The photocoagulation lasers segment dominated the global market, accounting for a share of nearly three-fourths of the total market in 2016.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/2013

The factors that drive the ophthalmic lasers market are surge in number of eye-related diseases, advancements in the laser technology, and increased awareness for laser application in the area of ophthalmology. However, stringent safety regulations and high rate of failure of surgeries involving use of lasers limit the market growth. Emerging nations, such as LAMEA and Asia-Pacific, and increasing disposable income are expected to provide major opportunities to the manufacturers of ophthalmic lasers.

The Nd:YAG lasers segment is expected to register highest CAGR of 5.2% from 2017 to 2018. This is attributed to diverse applications of these lasers in the treatment of various eye diseases.

In 2016, North America accounted for a share of two-fifths of the global market, owing to the increase in prevalence of eye-related diseases and high adoption of technologically advanced products. Europe holds the second position in the global ophthalmic lasers market.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/2013

The major companies profiled Are:

Carl Ziess Meditec Ag, Novartis AG, Topcon Corporation, Ellex Medical Corporation, Quantel Inc., Iridex Corporation, Nidek Co., LTD., Lumenis, Abbott Laboratories, and Ziemer Ophthalmic Systems.

Key Findings of the Ophthalmic Lasers Market:

• The photodisruption lasers segment is projected to grow at CAGR of 3.0% during the forecast period.
• North America accounted for a dominant position in the regional landscape in 2016, accounting for two-fifths share of the total market.
• In 2016, the eye clinics segment accounted for a share of more than one-fourth of the total ophthalmic lasers market.
• The glaucoma surgery segment accounted for the highest CAGR of 6.6% in the global ophthalmic lasers market, by application in 2016.

Access Full Report @ https://www.alliedmarketresearch.com/ophthalmic-laser-market

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Medical personal protective industry – Know Latest Trends & Forecast for Long-Term Business Planning

Coronavirus (COVID-19) was recognized in late December in Hubei province of Wuhan city in China. This highly contagious disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from humans to humans. After the first case in Wuhan, the disease rapidly spread to other parts of the globe. On March 11, 2020, the World Health Organization (WHO) made an assessment that COVID-19 can be characterized as a pandemic. Thus, social-distancing became an important measure to stop the spread of this disease. Various countries across the world adopted nationwide lockdowns. This led to a completely new scenario for the world, where every business in each industry faced new challenges and witnessed new opportunities. Similarly, the medical personal protective industry, a vital part of the healthcare sector, also witnessed new growth opportunities.

At present, the medical personal protective industry is witnessing a tremendous growth as medical personal protective products are playing a crucial role to combat the pandemic and monitor the patients. The medical personal protective products such as gowns, gloves, sets, coveralls, masks, caps, shoe covers, and others are facing a huge demand, owing to their immense usage in hospitals, clinics, and other healthcare service centers. The medical personal protective industry manufacturers are expanding their production capacity to manufacture products in response to the COVID-19 pandemic. Rise in the number of COVID-19 cases worldwide and the surge in need for healthcare workers are the factors expected to drive the demand for medical personal protective products. In addition, due to the quick spread of the virus, healthcare professionals associated with collection of specimens require proper protection including coveralls, masks, caps, and others to prevent themselves from getting infected. Moreover, medical nonwoven products form a crucial part of the personal protective equipment (PPE) worn by healthcare professionals. Therefore, growth in prevalence of contagious diseases and COVID-19 is anticipated to fuel the growth of the medical personal protective industry.

However, the outbreak led to a sudden change in scenario, sending mixed waves to the business flow. Some parts of the industry were hit in a negative manner whereas others experienced growth, owing to unexpected rise in demand for products and shortage of medical personal protective products in some countries.

Impact of COVID-19 on several industries in context with the medical personal protective industry

The medical personal protective products are used to protect the wearer and/or the patient from the spread of illness or infection during medical procedures and examinations. The medical personal protective products typically include gowns, gloves, sets, coveralls, masks, goggles, head caps, and shoe covers. Gloves are a type of personal protective equipment (PPE) designed to protect staff from microbial contamination, or from contact with certain chemicals, and cross-transmission from healthcare associated infections. Gowns are safe, comfortable, and flexible, and are used by physicians and other medical personnel to protect them from infectious fluids, bacteria, and viruses. Coverall is a one of the solutions of protective apparel that covers all the wearer to prevent the cross-contamination during work activities. These medical protective clothing are aimed to cover the entire body, including head, lower legs, back, and in some cases, feet. Masks are used to ensure an efficient filtration of the breath and are widely used in prevention of airborne diseases during an epidemic or pandemic. The caps are chiefly used by the surgical staff to prevent the hair strands or dandruff particles from contaminating a sterile area. Shoe covers are used by patients and physicians to prevent the transmission of infections into the operation theatre through the footwear.

The COVID-19 outbreak impacted the medical personal protective segment in a positive manner. The COVID-19 virus is mostly transmitted through the respiratory routes and supposedly by transfusions. Social-distancing is observed as an effective measure to stop the spread of COVID-19 disease and has triggered the demand for gloves, surgical masks, and N95 respirators, since masks are considered to be the first line of defense against the viral infection. Moreover, WHO, in March 2020, advised and recommended wearing a mask in public spaces as a measure to curb the spread of coronavirus. Recently, government of India (GOI) made the masks mandatory for employees and laborers working across all industry verticals such as manufacturing, aerospace, and healthcare sectors, to combat the COVID-19 outbreak. In addition, in May 2020, Centers for Disease Control and Prevention (CDC) recommended that the use of the gloves should be during food handling, cleaning, gardening, trades, or caring for someone who is sick, and while in contact with blood, stool, or body fluids, such as saliva, mucus, vomit, and urine. If gloves are not used appropriately, they can pose a risk of spreading germs, putting workers and others at risks.

The manufacture of medical gloves for health workers is one industry that has experienced significant growth, with over 300 billion rubber gloves now being used each year. The Malaysian firm Meditech Gloves is expected to begin production of natural gloves that can biodegrade 100 times faster than synthetic, petroleum-based options. Key players of gloves such as Supermax Corporation Berhad and Top Glove Corporation Bhd., and others are focusing toward increase in production of gloves to sustain the pandemic. While the COVID-19 pandemic rages across the world, the demand for medical gloves has increased globally.

However, trade and transport restrictions, quarantine measures, cross-border movement controls, and disruptions in production have reduced the supply of medical personal protective products across the world. One of the major mask manufacturers and suppliers is China, which was under lockdown for months. This has adversely affected the surgical product supply chain activities across the globe. Subsequently, several domestic manufacturers have stepped in for manufacturing medical personal protective products in several countries. The companies are facing substantial challenges to ramp up the production capacities to help mitigate the medical personal protective products supply shortage. These challenges are expected to pose a threat to the growth of the medical personal protective industry in the coming years. However, the market players are strategically planning to strengthen the production capacities of products by collaborating with other companies to overcome the shortage.

TABLE 01.      GLOBAL GLOVES MARKET, 2017–2025 ($Million)

	2017	2018	2019	2020	2021	2022	2023	2024	2025
Global Market	11,460.63	12,471.83	13,422.02	17,882.10	23,693.78	27,603.26	30,170.36	32,553.82	35,027.91

Source: Primary & Secondary Research and AMR Analysis

TABLE 02.       Europe nonwoven products market, 2017–2025 ($THOUSAND)

	2017	2018	2019	2020	2021	2022	2023	2024	2025
Global Market	1,528,922.4	1,631,912.6	1,723,636.5	5,868,821.7	2,617,494.5	2,485,578.5	2,615,077.1	2,793,686.9	3,014,667.5

Source: Primary & Secondary Research and AMR Analysis

Expectations from the medical personal protective industry

The coronavirus (COVID-19) pandemic is a constantly-evolving condition that is affecting all communities across the globe. The medical personal protective industry should monitor all developments and adhere to recommendations from the Center of Disease Control (CDC) and World Health Organization (WHO), and local & state health agencies. The medical personal protective manufacturer should implement all recommended safety precautions and take additional steps to avoid spread of COVID-19 within their production area. The manufacturer should follow recommended guidelines for risk reduction such as social distancing, frequent disinfection to high touch items, availability of hand sanitizers in all common areas, and provision of training and updates to all employees on safety precautions. Moreover, the quality of the product should not be affected, as demand for medical personal protective is more.  

Major medical personal protective key players are 3M Company, Asahi Kasei Corporation, B. Braun Melsungen AG, Cardinal Health, Freudenberg & Co. KG, Hartmann Group, Investor AB (Mölnlycke Health Care AB), Kimberly-Clark Corporation, Hartalega Holdings Berhad, Honeywell International Inc., Medline Industries, Inc., and Zarys International Group. The expectation from the medical personal protective industry is to support governments to fight against the COVID-19. For instance, in November 2020, four major glove companies namely Top Glove Corp Bhd., Hartalega Holdings Bhd., Supermax Corporation Bhd., and Kossan Rubber Industries Bhd., contributed $98.70 million to help the government in its fight against COVID-19. Furthermore, in March 2020, Supermax Corporation Berhad has donates 1 million nitrile powder-free medical gloves to COVID-19 frontlines. They are to be distributed to Malaysian government hospitals, police stations, and the healthcare industry’s first responders, to combat the COVID-19 outbreak in Malaysia.

Post COVID-19 Scenario

As nations are emerging out of strict lockdowns, economy is expected to take time to stabilize gradually. Players operating in the medical personal protective industry are anticipated to face new challenges related to different aspects. For instance, products shortage would lead to a negative impact on supply to various countries. However, the scenario is expected to change upon increasing the production of medical personal protective products. Similarly, decision making management of medical personal protective companies is anticipated to face challenges such as improvement of liquidity, management of working capital, better management of expenditures, and redefined contracts with suppliers. Pending surgical procedures are expected to be completed post COVID-19 pandemic. Such number of pending or suspended surgeries is expected to result into an exponential growth of the medical personal protective industry along with recovery from COVID pandemic.

Recent news in the medical personal protective industry during the pandemic

The medical personal protective key players around the globe are entering into collaboration and partnership.

In September 2020, SHOWA, a U.S. manufacturer of single-use PPE gloves, and Choctaw Kaul Distribution Company announced a strategic partnership to meet the rise in U.S. demand for Personal Protective Equipment (PPE) gloves that are critical to protecting the U.S. frontline workers and citizens during the COVID-19 pandemic.

In August 2020, Ansell Healthcare Products LLC, a global leader in hand protection solutions has signed a distribution partnership with OneMed; a provider of medical supplies and support systems which has an existing distribution network in the Nordics.

In May 2020, Dow collaborated with nine key partners across myriad of industries to develop & donate 100,000 isolation gowns to support frontline workers in Texas, Louisiana and Mexico.

In April 2020, Nature Works and the Nonwovens Institute (NWI) announced a strategic partnership to produce at least 10 million N95 surgical masks.

Medical Device Outsourcing Market: Comprehensive study explores Huge Growth in near Future

Medical device outsourcing involves taking the assistance of third-party companies to manufacture medical devices. Increase in geriatric population and rise in number of patients suffering from chronic disorders, such as spine disorders, diabetes, and cardiovascular diseases, are expected to drive the market growth. Moreover, outsourcing also allows the companies to focus on their core activities, which in turn boosts the market growth. However, threat of loss of confidential information is expected to impede the market growth.

The global medical device outsourcing market was valued at $44,326 million in 2016, and is projected to reach $83,952 million by 2023, growing at a CAGR of 9.5% from 2017 to 2023. The electronics segment held more than two-fifth share of the total market in 2016.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/1436

Finished device manufacturing segment is expected to dominate the market throughout the analysis period, owing to increase in demand for affordable devices. Testing and regulatory support services is expected to register highest CAGR of 10.0% during the forecast period.

Asia-Pacific is projected to register the highest CAGR of 10.5% during the forecast period, owing to low labor costs, low overhead expenses, and improving technical abilities to produce class III medical devices. In addition, tax breaks and incentives such as lowered tariffs and duties to foreign companies in these nations offer a lucrative opportunity for the market growth.

The Major Key Players Are:

• Celestica, Inc.
• Creganna
• Flextronics International Ltd.
• Heraeus Holding
• Integer Holdings Corporation
• Nortech Systems, Inc.
• Plexus Corp.
• Sanmina Corporation
• Tecomet, Inc.
• West Pharmaceutical Services, Inc.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/1436

Key Findings of the Medical Device Outsourcing Market:

• Finished goods segment is projected to grow at a CAGR of 10.0% during the forecast period.
• Class II devices accounted for more than half of the share of the global medical device outsourcing market, in 2016.
• In terms of application, cardiovascular segment is expected to register the highest CAGR of 9.9% during the analysis period.
• Prototype & development is expected to grow at the CAGR of 10.0% during the forecast period.
• France and Germany collectively contributed for more than two-fifth share of the European medical device outsourcing market in 2016.
• Japan is the major shareholder, accounting for more than one-third share of the Asia-Pacific medical device outsourcing market in 2016.

Access Full Report @ https://www.alliedmarketresearch.com/medical-devices-outsourcing-market

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com